TY - JOUR T1 - Kinevac Stability After Reconstitution with Sodium Chloride Injection USP, 0.9% JF - Journal of Nuclear Medicine Technology JO - J. Nucl. Med. Technol. SP - 57 LP - 59 DO - 10.2967/jnmt.108.050732 VL - 37 IS - 1 AU - Latisha T. Littleton AU - Bader B. Fileta AU - Robert Massey AU - Timothy I. Wood Y1 - 2009/03/01 UR - http://tech.snmjournals.org/content/37/1/57.abstract N2 - Our objective was to compare the stability of Kinevac when reconstituted with sodium chloride injection, USP, 0.9%, versus the manufacturer's recommended sterile water for injection, USP, and to determine the effects on stability of deviating from the manufacturer's recommended methods of product preparation. Methods: Kinevac was reconstituted with either sterile water or 0.9% sodium chloride. Triplicate high-performance liquid chromatography was performed on each vial of reconstituted sample at time zero and at time zero plus 8 h. The concentration of each sample, as measured by the peak area, was recorded at each time point. The process was repeated over 4 consecutive days. Results: Kinevac reconstituted with sterile water resulted in the recovery of 89.73% of the time zero concentration after 8 h. Kinevac reconstituted with 0.9% sodium chloride resulted in chemical stability of the injection, with 80.05% recovery of the time zero value after 8 h. Conclusion: Kinevac is more stable when reconstituted with sterile water than when reconstituted with 0.9% sodium chloride. Kinevac should be reconstituted with sterile water for injection as per the manufacturer's instructions. ER -